Clinical Trial

This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is an early exploratory study to assess the tolerability and safety of GC012F CAR T cell injection in Multiple Sclerosis patients.
Protocol Amendment History 1 change
notable Enrollment reduced: 15 -> 9 participants 2026-05-23
Trial Details
NCT Number NCT07303790
Lead Sponsor Daishi Tian
Conditions Multiple Sclerosis
Enrollment 9 participants
Start Date 2026-03-09
Primary Completion 2027-01-20 (estimated)
Study Completion 2028-12-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-22